Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2008-05-31
2011-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of a Slotted Anoscope That Facilitates Hemorrhoidectomy
NCT01264835
Use of Human Dehydrated Amnion Chorion Allograft in Closed Hemorroidectomy
NCT03479489
Effectiveness of Anal Enlargement by Dilators as a Therapeutic Physical Tool in Acute Anal Fissure
NCT04828889
Safety and Efficacy Study of HET Bipolar System for Treatment of Stage I and Stage II Hemorrhoids
NCT01841970
Stapled Anopexy Versus Closed Haemorrhoidectomy for Haemorrhoids
NCT00397137
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Stricture or narrowing of the anal canal after hemorrhoidectomy is the direct result of excising too much anoderm and mucosa. Even in circumferential prolapsed hemorrhoids, a standard three quadrant hemorrhoidectomy is all that is necessary. Mild anal stricture can be treated with a Hegar dilator but severe stricture requires a lateral internal sphincterotomy with or without a skin advancement flap. These operations are morbid and results are generally poor.
Anal sensation is partially impaired leading to some degree of incontinence of 50% of patients after hemorrhoidectomy. Persistent incontinence results from being over aggressive during the hemorrhoidectomy and excising muscle with the hemorrhoid during dissection.
The majority of these long term complications are solely dependent on surgical technique. The majority of hemorrhoidectomies performed today are still performed by non-specialty surgeons. They rely on various instruments during the surgery to perform the operation in the anal canal with adequate exposure but the most important instrument is the anoscope.
A variety of anoscopes are currently available, but the standard anoscope used for hemorrhoidectomy is the Hill-Ferguson. The Hill-Ferguson is a crescent shaped instrument that provides adequate exposure in the anal canal and allows the surgeon to perform a Ferguson hemorrhoidectomy, the standard of care for hemorrhoidectomy in this country. During this procedure an elliptical excision is begun at the perianal skin to include both external and internal hemorrhoids and is ended at the anorectal ring. A full thickness of mucosa and submucosa is excised and the surgeon should dissect superficial to the internal sphincter muscle. The strip of this excision should be no wider than 1.5 cm but currently nothing prevents the surgeon from exceeding this limitation or from taking muscle with the excision. The widely accepted Hill-Ferguson Anoscopes provide vast exposure but do not set any boundaries for the surgeon when performing this operation.
Over the last several decades few modifications have been introduced to alter the contour of the anoscope in an attempt to reduce the complications of post-operative stricture and incontinence. Furthermore, the current anoscopes lack the ability to outline a precise excision path for the infrequent anorectal surgeon or for the non-specialist in the community.
Recently, Ethicon surgical has developed an anoscope that outlines the precise path for hemorrhoid excision without the possibility of excision greater than 1.5 cm of anoderm with each excision. This instrument allows the standard of care Ferguson hemorrhoidectomy to be performed and does not alter the steps of the operation. The presumed advantages are the ability of the instrument to guide an accurate dissection and also to decrease the overall time it takes to perform hemorrhoidectomy. It has been tested in several porcine models. Operative times, tissue excised, and evaluation of the suture line were addressed during these trials and there were no instances of bleeding or excessive tissue excision.
The study design will be a prospective feasibility trial. Patients who are scheduled for operative excisional hemorrhoidectomy will undergo their planned procedure according to the standard of care which is a Ferguson hemorrhoidectomy. The only new variable introduced will be the application of a new anoscope to facilitate the dissection. Other than the new anoscope all pre-operative, intra-operative, and post-operative guidelines consistent with the current standards will be followed. The primary goal is to confirm that the new anoscope permits standard hemorrhoidectomy, and to obtain phase I data confirming that this novel anoscope is safe and efficacious in the performance of a Ferguson hemorrhoidectomy.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DEVICE_FEASIBILITY
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Circular anal dilator
Circular anal dilator group-An anoscope has been developed that outlines the precise path for hemorrhoid excision. This instrument allows a modified Ferguson hemorrhoidectomy to be performed and does not alter the steps of the operation.
Circular Anal Dilator for Transanal Hemorrhoidectomy
The Circular Anal Dilator for Transanal Hemorrhoidectomy (product #CAD01) allows the standard of care Ferguson hemorrhoidectomy to be performed and does not alter the steps of the operation. The presumed advantages are the ability of the dilator to guide an accurate dissection and also to decrease the overall time it takes to perform hemorrhoidectomy.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Circular Anal Dilator for Transanal Hemorrhoidectomy
The Circular Anal Dilator for Transanal Hemorrhoidectomy (product #CAD01) allows the standard of care Ferguson hemorrhoidectomy to be performed and does not alter the steps of the operation. The presumed advantages are the ability of the dilator to guide an accurate dissection and also to decrease the overall time it takes to perform hemorrhoidectomy.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects who have failed, or are not suitable for office management of their hemorrhoids.
* Subjects who are 18 years of age and older
* Subjects of either gender
* Subjects, who are willing and able to adhere to protocol requirements, agree to participate in the study program and provide written and informed consent
Exclusion Criteria
* Subjects with internal hemorrhoids that may be suitable for office management.
* Subjects with incontinence.
* Subjects with evidence of acute sepsis or the presence of a fistula.
* Subjects with a medical condition that may interfere with the evaluation of safety or effectiveness of the study device.
* Subjects who have another condition that in the opinion of the investigator precludes further participation in the study.
* Subjects with an anal stricture.
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ethicon, Inc.
INDUSTRY
University Hospitals Cleveland Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bradley Champagne, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospitals Cleveland Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospitals of Cleveland Case Medical Center
Cleveland, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
07-07-06
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.